{
    "2018-03-15": [
        [
            {
                "time": "2018-03-01",
                "original_text": "Why Akcea Therapeutics, Inc. Is Soaring While Ionis Pharmaceuticals Is Dropping",
                "features": {
                    "keywords": [
                        "Akcea Therapeutics",
                        "Ionis Pharmaceuticals",
                        "soaring",
                        "dropping"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-05",
                "original_text": "What Analysts Recommend for Novartis in March 2018",
                "features": {
                    "keywords": [
                        "analysts",
                        "recommend",
                        "Novartis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-07",
                "original_text": "How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "cancer treatment",
                        "plans"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-10",
                "original_text": "Must-Know Recent Developments from Novartis",
                "features": {
                    "keywords": [
                        "recent developments",
                        "Novartis"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "How Novartisâ€™s Alcon Performed in 4Q17",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Alcon",
                        "4Q17",
                        "performance"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "ophthalmology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Swiss Pharma Gets a Taste of Silicon Valley",
                "features": {
                    "keywords": [
                        "Swiss Pharma",
                        "Silicon Valley",
                        "innovation"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}